Skip to content
DraconiticResearch
Search Sources API
224,311 studies31 sourcesUpdated 50 min ago

Oncology

5,695 studies449 in 7 days2,628 in 30 days

Filters
Type
Date
Clear

Latest

5,695 studies

  1. Lumican - derived peptides inhibit melanoma cell growth and migration.
    Katarzyna Pietraszek-Gremplewicz, Stéphane Brézillon, Corinne Perreau +3
    PLoS ONEPeer-reviewedCC BY 4.0Full text65 citedOncologyPharmacology & toxicologyHAL
  2. Molecular Evolution of the Thermosensitive PAb1620 Epitope of Human p53 by DNA Shuffling
    Dimitris Xirodimas, David Lane
    Journal of Biological ChemistryPeer-reviewedCC BY25 citedOncologyHAL
  3. Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo
    Mark Saville, Alison Sparks, Dimitris Xirodimas +5
    Journal of Biological ChemistryPeer-reviewedCC BY158 citedOncologyHAL
  4. p14 Arf Promotes Small Ubiquitin-like Modifier Conjugation of Werners Helicase
    Yvonne Woods, Dimitris Xirodimas, Alan Prescott +3
    Journal of Biological ChemistryPeer-reviewedCC BY59 citedOncologyHAL
  5. Perturbation of 60 S Ribosomal Biogenesis Results in Ribosomal Protein L5- and L11-dependent p53 Activation
    Xiao-Xin Sun, Yue-Gang Wang, Dimitris Xirodimas +1
    Journal of Biological ChemistryPeer-reviewedCC BYFull text80 citedOncologyHAL
  6. Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation
    Nieves Embade, David Fernández-Ramos, Marta Varela-Rey +14
    HepatologyPeer-reviewedLicence not stated1 citedOncologyHAL
  7. Troponin I Surveillance to Risk-Stratify Early Events After Immune Checkpoint Inhibitor Initiation.
    Hiroyuki Fujii, Yuichi Tamura, Masao Daimon +8
    Circulation reportsPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  8. Contextual assessment of perceived health system alignment with National Standards for Cancer Survivorship Care in the American Southeast
    Shirley M. Bluethmann, Stephanie Bunch, Chandylen Nightingale +9
    Journal of Cancer SurvivorshipPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC
  9. Neuropilin-1 is involved in lytic replication in a subset of primary effusion lymphoma cell lines and for KSHV gene expression in primary endothelial cells
    Anna K. P. Serquina, Julie Lee, Eric Cho +3
    mBioPeer-reviewedCC BYFull textOncologyPMC
  10. Single-cell tracking reveals tumor-reactive T cell plasticity during melanoma TIL therapy
    Michael T. Sandholzer, Clara Serger, Alessia G. Liner +19
    Cell Reports MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  11. Benchmarking of bulk transcriptomic harmonization tools in a multi-platform B-cell lymphoma cohort identifies feature-specific quantile normalization and surrogate variable analysis as top-performing methods
    D. Nikitin, N. M. Borisov, M. Savchenko +9
    bioRxivPreprintCC BYFull text1 citedOncologybioRxiv
  12. Melanoma evolution in the lymph node shapes systemic outcomes
    K. S. Ventre, T. Muijlwijk, R. Stagnitta +9
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  13. C1q from C1q+ tumor-associated myeloid cells promotes resistance to T-cell engagers and CAR T-cells and is induced by LIF and glucocorticoids
    M. Lopez Vazquez, S. Espinosa Gil, R. Iurlaro +20
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  14. The atypical cadherin CELSR2 regulates distinct epithelial-mesenchymal states and oxidative phosphorylation in triple-negative breast cancer
    J. Koren, N.-I. Y. Saidani, A. El kaoutari +13
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  15. A Causal Multi-modal AI Model Stratifies Residual Risk and Identifies Candidates for Treatment Escalation in Node-Positive HR+/HER2- Early Breast Cancer
    T. Bachelot, S. Chabaud, J. Lemonnier +11
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  16. Cancer type-specific profiling of chromatin regulator mutations identifies recurrent and co-occurring gene sets associated with improved survival following immune checkpoint therapy
    D. Bukovec, M. Gjorgjievska, S. Kocevska +5
    medRxivPreprintAll rights reservedFull textOncologymedRxiv
  17. Metabolic profiling of CAR T-cells in patients reveals a shift toward amino acid-supported OXPHOS and informs transporter engineering
    Naomi Taylor, Josquin Moraly, Taisuke Kondo +29
    HALPreprintCC BYFull textOncologyHAL
  18. STAT3 inhibition for the induction of immunogenic cell death in multiple myeloma
    Oliver Kepp, Guido Kroemer
    OncoImmunologyPeer-reviewedCC BY 4.0Full textOncologyHAL
  19. Spatial clustering of esophageal cancer in central Oromia, Ethiopia: A spatial autocorrelation and scan statistics analysis
    Teresa Kisi Beyen, Edom Seife, Biniyam Tefera Deressa +2
    PLOS OnePeer-reviewedCC BY 4.0OncologyPLOS
  20. Patient-specific integration of RNA expression, methylation-derived replication-timing proxies, and histomorphology for pancreatic cancer subtyping
    Alejandro Leyva, M. Khalid Khan Niazi
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  21. Bacterial RNA downregulates MHC-I in tumor cell lines, promoting NK response and delaying tumor growth
    Agustina Serafino, Mónica Vermeulen, Yasmín A. Bertinat +7
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPLOS
  22. Orchestration of kaempferol nuclear translocation by phase ii metabolic enzymes and efflux transporters suppresses colorectal cancer
    Chishun Zhou, Qing Ning, Xin Jin +8
    PLOS OnePeer-reviewedCC BY 4.0Full textOncologyPharmacology & toxicologyPLOS
  23. Choroid plexus volume variation in patients with gliomas, glioneuronal and neuronal tumors: Associations with tumor characteristics
    Jia Sun, Minghao Wu, Junjie Li +8
    PLOS OnePeer-reviewedCC BY 4.0Full textMedical imaging & radiologyOncologyPhysiologyPLOS
  24. R-package agentBayes: Likelihood-based statistical methods for agent-based models
    Niklas Moser, Dmitri Finkelshtein, Georgy Chargaziya +5
    PLOS Computational BiologyPeer-reviewedCC BY 4.0Full textOncologyPLOS
  25. Epstein-Barr virus-encoded microRNA-BART17-5p suppresses cell proliferation and metastasis by targeting CERK
    Peilin Wu, Xiazhen Xu, Qiong Wu +5
    PLOS PathogensPeer-reviewedCC BY 4.0Full textOncologyPLOS